On Wednesday, GSK plc (NYSE:GSK) reached agreements with ten plaintiff firms representing approximately 80,000 Zantac product liability cases in the U.S. state courts. These cases account for 93% of ...

A Delaware judge has dismissed a request from GSK Plc (NYSE:GSK) and other pharmaceutical companies to appeal a ruling that allows over 70,000 lawsuits alleging the heartburn drug Zantac causes cancer ...

How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...

Sanofi SA said it has agreed to settle approximately 4,000 lawsuits accusing the French drugmaker of selling its Zantac heartburn medicine without warning patients that it could cause cancer. The pact ...

When online pharmacy Valisure discovered high levels of a likely carcinogen in Zantac and its generic copycats in 2019, global recalls ensued. Contamination was one fear, but the bigger issue, as ...

Who Can File a Zantac (Ranitidine) Lawsuit to Recover Damages? As of April 2020, the Food and Drug Administration requested that all manufacturers of prescription and over-the-counter Zantac and other ...

Investors and analysts are only now starting to pay serious attention to GSK's potential historical liabilities relating to Zantac (ranitidine). GSK has been named as a defendant in approximately ...